The circadian timing system in clinical oncology
2014 · Annals of Medicine · 210 citations
https://doi.org/10.3109/07853890.2014.916990
P
Pasquale F. Innominato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
174
Papers
5.5K
Citations
43
h-index
70
i10-index
Pasquale F. Innominato is an academic researcher from Betsi Cadwaladr University Health Board. The author has contributed to research in topics: Circadian rhythm and melatonin & Colorectal Cancer Treatments and Studies & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 43, co-authored 148 publications.
ORCID: 0000-0002-0653-8261Papers by this author
worksConversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
2015 · Annals of Oncology · 145 citations
https://doi.org/10.1093/annonc/mdv548
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
2023 · The Lancet Oncology · 77 citations
https://doi.org/10.1016/s1470-2045(22)00793-8
Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis
2024 · ESMO Open · 61 citations
https://doi.org/10.1016/j.esmoop.2023.102220
Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy?
2024 · British Journal of Cancer · 51 citations
https://doi.org/10.1038/s41416-024-02704-9
Several clock genes polymorphisms are meaningful risk factors in the development and severity of cannabis addiction
2018 · Chronobiology International · 16 citations
https://doi.org/10.1080/07420528.2018.1523797
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat